Key Takeaways
Judge private equity by who carries the debt, not who books the gain.
The deal's basic mechanics. A leveraged buyout, or LBO, is a purchase financed largely with borrowed money. The acquired company often takes on much of that debt, then must cover interest through its operations. Owners may sell assets, cut costs, or borrow again to extract cash. The authors argue that this can shift risk from investors to workers, customers, creditors, and taxpayers while concentrating gains among the dealmakers.
The failure rate matters. A 2019 study cited in the book found that 20 percent of companies acquired by private equity filed for bankruptcy within ten years, compared with 2 percent of other acquired companies. Supporters say takeovers can rescue underperformers and improve efficiency. The concern is not that every deal fails, but that a company can be weakened by debt and fees before its owners face comparable risk.
The key test is not simply whether an investor earns a return, but whether that return reflects new value or a transfer of existing value and risk. This is an agency problem: managers decide how much debt a company can bear, while employees and communities may absorb the consequences without having a vote. Yet bankruptcy rates alone cannot establish that a buyout caused each failure. A careful assessment also needs a credible comparison with what would have happened under the previous owner, especially in industries facing technological or economic disruption.
Watch for debt-funded dividends that repay owners before firms can reinvest.
Cash out early. A dividend recapitalization occurs when a company borrows money to pay a dividend to its owners. The owners receive cash, but the company inherits more debt and larger interest obligations. Apollo used this approach at Noranda Aluminum shortly after buying it in 2007. Apollo put in about $214 million, while Noranda borrowed roughly $1 billion to finance the takeover. Three weeks after the purchase, it borrowed another $220 million and paid that amount to investors, allowing Apollo to recover its initial investment almost immediately.
The bill kept growing. Noranda's long-term debt rose from about $160 million before the deal to $1.15 billion afterward. Apollo extracted more than $400 million in dividends over five years, then sold its remaining stake in 2015. Noranda went bankrupt the following year, and the New Madrid smelter closed.
Debt can fund productive expansion, so borrowing is not itself evidence of misconduct. The revealing question is what the borrowed money buys. A dividend recapitalization pays owners today while reducing the company's room to weather a downturn, invest in equipment, or retain workers. In corporate finance, this resembles a distribution that privatizes upside while leaving operational risk behind. Noranda's failure also shows why short-term cash received by investors is an incomplete measure of success: the local tax base, pension system, and workforce were part of the economic cost.
A regulator's rushed sale can turn policyholders' safety net into a financier's windfall.
A rescue with losers. Executive Life Insurance had more than 300,000 policyholders and a large portfolio of risky bonds. In 1991, California Insurance Commissioner John Garamendi seized the company and arranged a sale of its bonds to a group involving Leon Black's Apollo and the French firm Altus. The buyers paid about $3.2 billion for the portfolio. Within two years, it was reportedly worth about $5.2 billion. A later state audit put policyholder losses above $3 billion.
The process shaped the outcome. The book reports that Garamendi did not establish the bonds' longer-term value before the sale, set the valuation date at the market's low point, and required an all-or-nothing purchase. A study cited by the authors estimated that a later valuation date could have left policyholders with $2.6 billion more. Katie Watson's family, whose contract funded her care after brain damage, received far less than promised.
The episode shows that emergency authority does not guarantee a fair emergency process. A regulator selling complex assets needs independent valuation, competitive bids, and public disclosure of conflicts, particularly when potential buyers have prior ties to the assets. The book's account is a forceful indictment, but insurance failures are genuinely difficult to resolve, and a failed insurer can leave policyholders exposed regardless of the chosen buyer. That makes transparent decision rules more important, not less: they allow the public to distinguish unavoidable losses from losses created by the resolution itself.
Count a town's jobs and tax base as part of a company's balance sheet.
A company supports more than owners. Noranda was New Madrid, Missouri's largest employer and a major contributor to local school funding. After the smelter closed in 2016, about $3.1 million in expected school revenue disappeared, roughly 17 percent of the district's budget. The town also lost jobs, household income, and pension security. Noranda's pension plans were underfunded by $219 million, leaving the taxpayer-backed Pension Benefit Guaranty Corporation to take them over.
The pattern reaches beyond one town. In a study of buyouts from 1980 to 2013, employment fell by 13 percent after private equity acquired a public company, and by 16 percent when it bought part of a company. Retailers owned by private equity eliminated more than half a million jobs between 2003 and early 2020. Online competition played a role in some closures, but debt and asset extraction also weakened companies.
Standard financial accounts record wages, taxes, and pension obligations, but they rarely capture the full local effects of a major employer's collapse. Those effects are economic spillovers: school budgets shrink, suppliers lose customers, and workers may have few comparable jobs nearby. Treating these consequences as external to the deal makes the transaction look more efficient than it is for society. Still, job losses can reflect automation, trade, or changing consumer behavior as well as ownership. A useful analysis separates those forces rather than assigning every decline to one cause.
In healthcare, fewer staff and higher billing can turn efficiency into patient harm.
Care has a cost. Private equity firms have bought hospitals, nursing homes, emergency-room staffing companies, and physician practices. The authors describe common tactics: reducing staffing, raising charges, selling property, and directing patients toward more profitable treatments. A 2021 study of nursing homes found 10 percent more resident deaths under private equity ownership than in comparable facilities, with reduced staffing and weaker compliance with care standards among the factors associated with the increase. Researchers estimated about 20,000 additional deaths across the years studied.
Emergency rooms show the conflict. Blackstone-owned TeamHealth removed emergency doctor Ming Lin after he spoke publicly about pandemic preparedness at his hospital. A Yale study found that after Envision took over emergency departments, patients faced higher charges and were more likely to be admitted. The companies say clinicians retain independent medical judgment, while critics argue that staffing, billing, and performance targets can shape care.
Healthcare is not an ordinary retail service. Hospitals and nursing homes need spare capacity, trained staff, and reliable supplies precisely because crises and unpredictable needs arise. What looks like unused capacity on a spreadsheet can function as resilience in practice. The nursing-home study gives the argument unusual weight because it measures patient outcomes, not only costs. Still, an average effect does not mean every facility or owner performs alike. Strong reporting should distinguish ownership's influence from regulation, local staffing shortages, and differences in the patients each facility serves.
Audit every fee against net returns, not the fund's glossy headline.
Fees can quietly compound. Private equity managers charge investors for managing funds and may also collect monitoring fees from companies they own. In some cases, companies paid fees covering years of future oversight even though the firm sold them before providing those services. The SEC found disclosure failures involving Apollo's monitoring fees and required the firm to pay $53 million, including money designated for affected investors.
Pensioners often bear the cost. Researchers at Harvard and Stanford examined $500 billion in private equity investments made by 200 public pension funds between 1990 and 2018. They estimated that fees reduced pension returns by $45 billion, nearly 10 percent of the amount invested. The book also notes that a California public pension for Ohio teachers paid about $143 million annually in fees on committed capital, including money not yet invested.
Fee analysis is a practical form of consumer protection for institutional investors. A fund's reported return can look impressive before management charges, performance fees, and other expenses are subtracted. Pension trustees therefore need comparisons that include net performance, risk, liquidity, and the cost of less transparent investments. The arrangement also creates a principal-agent conflict: managers are paid for overseeing assets, while beneficiaries depend on the assets to fund retirement. Private equity can still be useful in a diversified portfolio, but its case should rest on measurable net benefits, not on prestige or promises of exceptional returns.
Follow actual control through shell companies before deciding who is accountable.
Ownership can disappear in the paperwork. Private equity firms often hold companies through layers of subsidiaries and contracts. In healthcare, staffing companies have used physician-owned practices on paper while retaining control over hiring, schedules, billing, and other operations. This structure can make it harder for patients, regulators, and workers to identify who is making decisions or who can be held responsible.
Small deals can hide consolidation. Private equity firms may buy many small practices that individually fall below federal merger-notification thresholds. The combined result can still reduce competition and increase prices. The authors also describe a 2007 lawsuit alleging that major firms coordinated with one another to keep takeover prices low. The firms settled for $590 million without admitting the allegations, and executives did not personally pay the settlement.
A legal entity is not always the same as the operational decision-maker. Corporate law uses separate entities to allocate risk and clarify responsibility, but the same separation can obscure who controls staffing, prices, and clinical policies. Regulation that examines only the name on a license or the size of one acquisition may miss the economic reality. The challenge is to define control carefully, rather than assume that every investor directs day-to-day decisions. Disclosure of ownership, contracts, and overlapping decision-makers is a necessary starting point for making that distinction.
Attach public-interest conditions whenever taxpayers stabilize private equity's bets.
Public money can protect private gains. During the COVID crisis, Apollo-owned LifePoint Health received $1.4 billion in federal assistance. The company cut staff pay and benefits by $166 million and reduced charity care by 21 percent. In 2021, Apollo sold its stake in LifePoint for a reported $1.6 billion gain. The book also describes federal support for the corporate bond market, which helped preserve a key source of financing for debt-heavy companies.
The pattern predates the pandemic. The authors report that Apollo and companies it owned received hundreds of millions of dollars in subsidies, contracts, loans, and guarantees from government bodies over several decades. Such support can be defensible when it preserves essential services or jobs. The concern is that assistance may shore up firms without requiring them to protect workers, maintain care, or return public funds if investors later profit.
Emergency support is not automatically a giveaway. Governments may need to stabilize hospitals, credit markets, and employment during a crisis. The policy question is whether public aid comes with enforceable public benefits. Conditions might link assistance to staffing, wages, service levels, disclosure, or repayment when a company later generates large gains. This is a question of reciprocity: when the public absorbs downside risk, it should have a claim on the upside or a guarantee that essential services continue. Without conditions, rescue programs can reward leverage while leaving the costs with taxpayers.
A pension transfer relocates risk; it does not make the promise safer.
Retirement promises change hands. Apollo created Athene, an insurer that sells annuities and takes over corporate pension obligations. By mid-2022, about 410,000 retirees depended on Athene for payments. In a pension risk transfer, a company transfers its pension obligations to an insurer, usually in exchange for a payment. The employer is relieved of future responsibility, but retirees may lose the protection they had from the Pension Benefit Guaranty Corporation if the insurer fails.
The insurer's investments matter. Athene invests in assets connected to Apollo and uses extensive reinsurance with affiliated companies. In 2020, 95 percent of one Athene unit's reinsurance and coinsurance arrangements were with affiliates. Such arrangements may concentrate risk rather than distribute it among independent firms. The book argues that policyholders can be left exposed to investment choices they cannot inspect or influence.
Insurance liabilities often stretch decades into the future, so their safety depends on asset quality, liquidity, and regulation over long periods. That is a different time horizon from a fund seeking to sell an investment after several years. Affiliate reinsurance deserves special scrutiny because risk sharing is less persuasive when the counterparties belong to the same corporate group. These facts do not prove that Athene will fail or that retirees will miss payments. They do show why a transfer should be judged by the strength of the new guarantor, not just the unchanged dollar amount of the benefit.
Make liability and antitrust rules follow control, even through small rollups.
Rules need teeth and visibility. The book's proposed responses include requiring clearer disclosure of ownership, fees, and conflicts; scrutinizing acquisitions that build market power through many small purchases; and making it harder to extract cash from a company close to bankruptcy. It also argues for stronger enforcement of laws limiting corporate control over medical decisions and for reconsidering tax advantages such as carried interest.
Some pressure is emerging. A federal judge's ruling in the Nine West bankruptcy said directors could face liability if they approved a sale without examining whether its debt structure was sustainable. The Federal Trade Commission has also challenged acquisitions in veterinary care that accumulated market power through rollups. Broader legislation, including the proposed Stop Wall Street Looting Act, did not pass. The authors conclude that rules are ineffective if regulators routinely waive or fail to enforce them.
No single reform can repair the incentives described here. Disclosure helps investors and the public see who owns and controls an operation; antitrust review addresses concentration; liability rules change the cost of reckless decisions; and enforcement makes all three credible. These measures should be designed with care so they do not accidentally burden ordinary small businesses or useful investment. A deeper institutional point is that public pensions and other investors can also exert pressure by demanding better terms and refusing opaque funds. Accountability works best when regulation and investor governance reinforce one another.
Analysis
The book's strongest contribution is not simply its argument that private equity can damage companies. It shows, transaction by transaction, how a recognizable financial mechanism can shift risk away from dealmakers and toward people who cannot readily refuse it. Debt lands on a portfolio company. Fees reduce the cash available to operate it. A sale transfers the asset, while liabilities remain with workers, policyholders, residents, or the public. Executive Life makes this pattern unusually vivid because one insurance rescue links a regulator, a distressed bond portfolio, hidden relationships, and a family dependent on promised payments. Noranda and healthcare cases show how similar incentives can produce different forms of harm.
The evidence is strongest where the authors connect a specific mechanism to measurable outcomes, such as higher debt, lower staffing, fees, or bankruptcy. The nursing-home mortality study and the pension-fee analysis carry more explanatory weight than anecdotes alone. Yet the book is investigative advocacy, not a neutral survey of every private equity transaction. It concentrates on harmful cases, and the counterfactual is difficult: some companies might have failed without a buyout, while others face competition, technological change, or public reimbursement rules unrelated to ownership. A rise in bankruptcy or a cut in employment does not, by itself, prove that a particular owner caused it.
That qualification does not erase the central institutional problem. Private firms can combine concentrated control with limited disclosure, while investors, workers, and regulators see only fragments of the operation. When the same firm earns fees, directs assets, influences financing, and sells the business, the usual division between owner, adviser, and creditor can blur. The book therefore points toward a better standard of judgment: trace cash, control, and downside exposure together. Ask not only whether the buyer made money, but whether the business became more productive, whether risks were honestly priced, and whether affected people had meaningful protection. That framework is more durable than treating every buyout as either a rescue or a raid.
Review Summary
These Are the Plunderers receives mixed reviews, with praise for its investigative journalism exposing private equity's negative impacts on businesses and communities. Critics appreciate the detailed examples and accessible explanations of complex financial concepts. However, some find the writing dry, repetitive, or overly biased. Readers express outrage at the practices described, though some desire more balanced analysis or proposed solutions. Overall, the book is seen as an important exposé of private equity's role in modern capitalism, despite its flaws in presentation.
People Also Read
Glossary
Leveraged buyout
Debt-financed company purchaseA leveraged buyout is an acquisition financed largely with borrowed money. The acquired company commonly carries much of the resulting debt, which must be repaid from its operations or assets. In the book's account, this can magnify investor returns but also leave the company less able to invest, withstand downturns, or protect jobs.
Dividend recapitalization
Debt-funded owner dividendA dividend recapitalization occurs when a company borrows money and distributes the proceeds to its owners as a dividend. The owners receive cash without selling their stake, while the company takes on additional debt and future interest costs. The book highlights this as a way investors can recover their investment early while increasing financial pressure on the acquired company.
Carried interest
Manager share of investment gainsCarried interest is the share of a private investment fund's profits paid to its managers, separate from recurring management fees. U.S. tax rules have often treated this income as capital gains rather than ordinary compensation, generally resulting in a lower tax rate. The book argues that this treatment helps private equity executives accumulate wealth and widens the tax burden between investors and wage earners.
Pension risk transfer
Pension obligations moved to insurerA pension risk transfer occurs when an employer shifts responsibility for some pension payments to an insurer, typically by purchasing an annuity or transferring a group of obligations. The employer reduces its future liabilities, but retirees now depend on the insurer's financial strength. The book stresses that a transfer changes who bears the risk and may remove protections previously associated with the employer's pension plan.
Corporate Practice of Medicine
Limits on corporate medical controlThe Corporate Practice of Medicine refers to state laws and legal doctrines that restrict corporations owned by non-physicians from practicing medicine or controlling physicians' clinical decisions. These rules are meant to protect medical judgment from financial pressure. The book describes how staffing companies may use physician-owned entities on paper while retaining practical control over hiring, billing, and operations.
Related party transactions
Deals between affiliated businessesRelated party transactions are business arrangements between companies or entities connected through common ownership or control. A healthcare facility, for example, might be required to buy billing, management, or property services from another company owned by its private equity sponsor. Such arrangements can create additional revenue for the sponsor and potential conflicts over whether the price and service are fair.
Money-for-nothing fees
Fees for unprovided future servicesThe book uses this phrase for monitoring fees collected in advance for years of future oversight, even when the private equity firm sells the company before providing those services. The fees can increase the sponsor's income while reducing the company's value and the money available to its investors, workers, and operations. The SEC challenged failures to disclose such practices.
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.